The impact of COVID-19 on the well-being and cognition of older adults living in the United States and Latin America.

Autor: Babulal GM; Washington University School of Medicine, St Louis, MO, USA., Torres VL; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA., Acosta D; Universidad Nacional Pedro Henriquez Urena, Santo Domingo, Dominican Republic., Agüero C; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA., Aguilar-Navarro S; Department of Geriatrics. Instituto Nacional de Ciencias Médicas y Nutrición 'Salvador Zubiran' Mexico City, Mexico., Amariglio R; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA., Ussui JA; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA., Baena A; Washington University School of Medicine, St Louis, MO, USA.; Grupo de Neurociencias de Antioquia, Universidad de Antioquia, Medellin, Colombia., Bocanegra Y; Grupo de Neurociencias de Antioquia, Universidad de Antioquia, Medellin, Colombia., Brucki SMD; University of São Paulo, Department of Neurology, São Paulo, Brasil., Bustin J; Institute of Cognitive and Translational Neuroscience (INCYT), INECO Foundation, Favaloro University, CONICET, Buenos Aires, Argentina., Cabrera DM; Universidad Peruana Cayetano Heredia, Lima, Peru., Custodio N; Unit Cognitive Impairment and Dementia Prevention, Peruvian Institute of Neurosciences, Lima, Peru., Diaz MM; Universidad Peruana Cayetano Heredia, Lima, Peru.; Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Peñailillo LD; Cognitive Disorders Unit - Neuromedicenter, Quito, Ecuador., Franco I; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA., Gatchel JR; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA., Garza-Naveda AP; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA., González Lara M; National Institute of Geriatrics, Mexico City, Mexico., Gutiérrez-Gutiérrez L; Department of Geriatrics. Instituto Nacional de Ciencias Médicas y Nutrición 'Salvador Zubiran' Mexico City, Mexico., Guzmán-Vélez E; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA., Hanseeuw BJ; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA.; Neurology Department, Cliniques Universitaires Saint-Luc, Belgium., Jimenez-Velazquez IZ; Geriatrics Division, Internal Medicine Department, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico., Rodríguez TL; Memory and Neuropsychiatric Clinic (CMYN), Neurology Department, Del Salvador Hospital and University of Chile School of Medicine, Santiago, Chile., Llibre-Guerra J; Washington University School of Medicine, St Louis, MO, USA., Marquine MJ; University of California San Diego, Department of Psychiatry, San Diego, CA, USA., Martinez J; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA., Medina LD; University of Houston, Department of Psychology, Houston, TX, USA., Miranda-Castillo C; Faculty of Nursing Universidad Andres Bello, Millennium Institute for Research in Depression and Personality, Santiago, Chile., Morlett Paredes A; University of California San Diego, Department of Neuroscience, San Diego, CA, USA., Munera D; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA., Nuñez-Herrera A; Cognitive Disorders Unit - Neuromedicenter, Quito, Ecuador., de Oliveira MO; University of São Paulo, Department of Neurology; São Paulo, Brasil., Palmer-Cancel SJ; Ponce Health Sciences University, School of Behavioral and Brain Sciences, Ponce, Puerto Rico., Pardilla-Delgado E; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA., Perales-Puchalt J; University of Kansas Alzheimer's Disease Center, Fairway, KS, USA., Pluim C; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA., Ramirez-Gomez L; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA., Rentz DM; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA., Rivera-Fernández C; Universidad Nacional de San Agustín de Arequipa, Perú., Rosselli M; Florida Atlantic University, Davie, FL, USA., Serrano CM; Neurology Department, Cesar Milstein Hospital, Buenos Aires, Argentina., Suing-Ortega MJ; Department of Geriatrics. Instituto Nacional de Ciencias Médicas y Nutrición 'Salvador Zubiran' Mexico City, Mexico., Slachevsky A; Memory and Neuropsychiatric Clinic (CMYN), Neurology Department, Del Salvador Hospital and University of Chile School of Medicine, Santiago, Chile., Soto-Añari M; Universidad Católica San Pablo, Arequipa, Perú., Sperling RA; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA., Torrente F; Institute of Cognitive and Translational Neuroscience (INCYT), INECO Foundation, Favaloro University, CONICET, Buenos Aires, Argentina., Thumala D; Psychology Department, Social Sciences Faculty, University of Chile, Geroscience Center for Brain Health and Metabolism (GERO), Santiago, Chile., Vannini P; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA., Vila-Castelar C; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA., Yañez-Escalante T; Universidad Nacional de San Agustín de Arequipa, Perú., Quiroz YT; Massachusetts General Hospital, Harvard Medical School, 1st Avenue, Suite 101, Boston 02129, MA, USA.
Jazyk: angličtina
Zdroj: EClinicalMedicine [EClinicalMedicine] 2021 Apr 27; Vol. 35, pp. 100848. Date of Electronic Publication: 2021 Apr 27 (Print Publication: 2021).
DOI: 10.1016/j.eclinm.2021.100848
Abstrakt: Background: In the COVID-19 pandemic, older adults from vulnerable ethnoracial groups are at high risk of infection, hospitalization, and death. We aimed to explore the pandemic's impact on the well-being and cognition of older adults living in the United States (US), Argentina, Chile, Mexico, and Peru.
Methods: 1,608 (646 White, 852 Latino, 77 Black, 33 Asian; 72% female) individuals from the US and four Latin American countries aged ≥ 55 years completed an online survey regarding well-being and cognition during the pandemic between May and September 2020. Outcome variables (pandemic impact, discrimination, loneliness, purpose of life, subjective cognitive concerns) were compared across four US ethnoracial groups and older adults living in Argentina, Chile, Mexico, and Peru.
Findings: Mean age for all participants was 66.7 ( SD  = 7.7) years and mean education was 15.4 ( SD  = 2.7) years. Compared to Whites, Latinos living in the US reported greater economic impact ( p  < .001, η p 2  =  0 .031); while Blacks reported experiencing discrimination more often ( p  < .001, η p 2  =  0 .050). Blacks and Latinos reported more positive coping ( p  < .001, η p 2  =  0. 040). Compared to Latinos living in the US, Latinos in Chile, Mexico, and Peru reported greater pandemic impact, Latinos in Mexico and Peru reported more positive coping, Latinos in Argentina, Mexico, and Peru had greater economic impact, and Latinos in Argentina, Chile, and Peru reported less discrimination.
Interpretation: The COVID-19 pandemic has differentially impacted the well-being of older ethnically diverse individuals in the US and Latin America. Future studies should examine how mediators like income and coping skills modify the pandemic's impact.
Funding: Massachusetts General Hospital Department of Psychiatry.
Competing Interests: Dr. Thumala reports personal fees from National Agency for Research and Development, during the conduct of the study. Dr. Miranda-Castillo reports grants and personal fees from National Agency for Research and Development, during the conduct of the study. Dr. Gatchel reports grants from NIH/NIA, grants from Alzheimer's Association, and served as a one-time consultant with Huron Consulting, outside the submitted work. Dr. Sperling reports personal fees from Roche, Takeda Pharmaceuticals, Eisai, Biogen, AC Immune, Neurocentria, Janssen, Neuraly, Alnylam Pharmaceuticals, Renew, JOMDD, Acumen, Prothena, Cytox, Oligomerix, Inc., and Genentech; grants from Eisai, Eli Lilly, Janssen, NIA, and Alzheimer's Association; personal fees and honorarium (consulting) for Dr. Sperling's spouse (Dr. Keith Johnson) from Novartis, AC Immune, Janssen, and Cerveau, outside the submitted work. Dr. Rentz reports consulting from Digital Cognition Technologies, Neurotrack, and Biogen Idec, outside the submitted work. All other authors have nothing to declare.
(© 2021 The Authors.)
Databáze: MEDLINE
Externí odkaz: